JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB192758

Anti-Kv1.2 antibody [K14/16]

Be the first to review this product! Submit a review

|

(5 Publications)

Mouse Monoclonal Kv1.2 antibody. Suitable for IHC-P, WB and reacts with Human, Rat, Mouse samples. Cited in 5 publications.

View Alternative Names

Potassium voltage-gated channel subfamily A member 2, NGK1, Voltage-gated K(+) channel HuKIV, Voltage-gated potassium channel HBK5, Voltage-gated potassium channel subunit Kv1.2, KCNA2

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kv1.2 antibody [K14/16] (AB192758)
  • IHC-P

Ap

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kv1.2 antibody [K14/16] (AB192758)

IHC image of Kv1.2 staining in Human normal cerebral cortex formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab192758, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre

Western blot - Anti-Kv1.2 antibody [K14/16] (AB192758)
  • WB

Lab

Western blot - Anti-Kv1.2 antibody [K14/16] (AB192758)

All lanes:

Western blot - Anti-Kv1.2 antibody [K14/16] (ab192758) at 5 µg/mL

Lane 1:

Human brain tissue lysate - total protein (<a href='/en-us/products/unavailable/human-brain-tissue-lysate-total-protein-ab29466'>ab29466</a>) at 10 µg

Lane 2:

Brain (Mouse) Tissue Lysate at 10 µg

Lane 3:

Brain (Rat) Tissue Lysate at 10 µg

Lane 4:

SHSY-5Y (Human neuroblastoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/50000 dilution

Predicted band size: 57 kDa

Observed band size: 70 kDa

true

Exposure time: 16min

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

K14/16

Isotype

IgG2b

Light chain type

kappa

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1-5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Kv1.2 also known as KCNA2 is a voltage-gated potassium channel subunit with a molecular mass of approximately 65 kDa. It plays a critical role in mediating potassium ion conductance across the cell membrane. Kv1.2 is expressed in the brain particularly in neurons but is also found in heart and other tissues. Its activity is essential for controlling the electrical excitability of cells by contributing to the repolarization phase of the action potential.
Biological function summary

The function of Kv1.2 involves regulating neuronal excitability and signaling. As a member of the wider Kv1 family it often assembles into tetrameric complexes with other Kv1 subunits to form functional channels. These complexes influence the duration and frequency of action potentials impacting synaptic transmission and plasticity which are important for normal nervous system function.

Pathways

Kv1.2 is involved in neuronal signaling pathways and cardiac action potential regulation. In the nervous system its activity affects neurotransmitter release by modulating the repolarization phase of action potentials. In the heart Kv1.2 plays a role in maintaining proper cardiac rhythm through its interaction with other potassium channels including Kv2.1. This interaction helps ensure that electrical signals in the heart and brain move smoothly.

Mutations or dysfunction in Kv1.2 are associated with certain neurological and cardiac conditions. In the nervous system alterations in Kv1.2 activity can contribute to epilepsy a disorder characterized by uncontrolled neuronal firing. In the heart abnormal Kv1.2 function may relate to arrhythmias which involve irregular heartbeats. The protein Kv2.1 which interacts with Kv1.2 also associates with these disorders highlighting the importance of proper channel function in maintaining healthy neurological and cardiac activities.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the cardiovascular system. Prevents aberrant action potential firing and regulates neuronal output. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane (PubMed : 11211111, PubMed : 19912772, PubMed : 23769686, PubMed : 8495559). Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, KCNA6, KCNA7, and possibly other family members as well; channel properties depend on the type of alpha subunits that are part of the channel (PubMed : 20220134, PubMed : 8495559). Channel properties are modulated by cytoplasmic beta subunits that regulate the subcellular location of the alpha subunits and promote rapid inactivation of delayed rectifier potassium channels. In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Homotetrameric KCNA2 forms a delayed-rectifier potassium channel that opens in response to membrane depolarization, followed by slow spontaneous channel closure (PubMed : 19912772, PubMed : 23769686). In contrast, a heteromultimer formed by KCNA2 and KCNA4 shows rapid inactivation (PubMed : 8495559). Regulates neuronal excitability and plays a role as pacemaker in the regulation of neuronal action potentials (By similarity). KCNA2-containing channels play a presynaptic role and prevent hyperexcitability and aberrant action potential firing (By similarity). Response to toxins that are selective for KCNA2-containing potassium channels suggests that in Purkinje cells, dendritic subthreshold KCNA2-containing potassium channels prevent random spontaneous calcium spikes, suppressing dendritic hyperexcitability without hindering the generation of somatic action potentials, and thereby play an important role in motor coordination (By similarity). Plays a role in the induction of long-term potentiation of neuron excitability in the CA3 layer of the hippocampus (By similarity). May function as down-stream effector for G protein-coupled receptors and inhibit GABAergic inputs to basolateral amygdala neurons (By similarity). May contribute to the regulation of neurotransmitter release, such as gamma-aminobutyric acid (GABA) (By similarity). Contributes to the regulation of the axonal release of the neurotransmitter dopamine (By similarity). Reduced KCNA2 expression plays a role in the perception of neuropathic pain after peripheral nerve injury, but not acute pain (By similarity). Plays a role in the regulation of the time spent in non-rapid eye movement (NREM) sleep (By similarity).
See full target information KCNA2

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2402086 PubMed38946582

2024

Branched-Chain Amino Acids Deficiency Promotes Diabetic Neuropathic Pain Through Upregulating LAT1 and Inhibiting Kv1.2 Channel.

Applications

Unspecified application

Species

Unspecified reactive species

Ze-Yu Zhou,Ji-Ying Wang,Zhi-Xiao Li,Hong-Li Zheng,Ya-Nan Zhou,Li-Na Huang,Li-Juan Wang,Xiao-Wei Ding,Xin Sun,Ke Cai,Rui Zhao,Yan Shi,Alex F Chen,Zhi-Qiang Pan,Jing Cao,Fu-Qing Lin,Jian-Yuan Zhao

Brain : a journal of neurology 145:1632-1640 PubMed35661858

2022

Sensory neurons have an axon initial segment that initiates spontaneous activity in neuropathic pain.

Applications

Unspecified application

Species

Unspecified reactive species

Ana I Nascimento,Tiago F Da Silva,Elisabete C Fernandes,Liliana L Luz,Fernando M Mar,Boris V Safronov,Monica M Sousa

Bioengineered 12:7470-7480 PubMed34632937

2021

Upregulation of ubiquitin conjugating enzyme E2B (Ube2b) ameliorates neuropathic pain by regulating Kcna2 (potassium voltage-gated channel subfamily A member 2) in primary afferent neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanzhi Peng,Qingqing Zhang,Hao Cheng,Guizhen Yan,Chunli Xing

Toxicological sciences : an official journal of th : PubMed31168611

2019

Demyelination-Remyelination in the Central Nervous System: Ligand-Dependent Participation of the Notch Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Patricia A Mathieu,María F Almeira Gubiani,Débora Rodríguez,Laura I Gómez Pinto,María de Luján Calcagno,Ana M Adamo

The Journal of cell biology 217:1353-1368 PubMed29434029

2018

De novo fatty acid synthesis by Schwann cells is essential for peripheral nervous system myelination.

Applications

Unspecified application

Species

Unspecified reactive species

Laura Montani,Jorge A Pereira,Camilla Norrmén,Hartmut B F Pohl,Elisa Tinelli,Martin Trötzmüller,Gianluca Figlia,Penelope Dimas,Belinda von Niederhäusern,Rachel Schwager,Sebastian Jessberger,Clay F Semenkovich,Harald C Köfeler,Ueli Suter
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com